Guiding the pulmonologist's hand: What they need to know about lung pathology and what is lost in translation

Archives of Pathology and Laboratory Medicine

Volumn 136, Issue 12, 2012, Pages 1528-1532

  Kradin, Richard L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; HUMAN; LUNG; LUNG DISEASE; MANPOWER; METHODOLOGY; PATHOLOGY; PROGNOSIS; PULMONOLOGY; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; BOSTON; HUMANS; LUNG; LUNG DISEASES; PATHOLOGY, CLINICAL; PROGNOSIS; PULMONARY MEDICINE;

EID: 84870924148     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2012-0273-SA     Document Type: Conference Paper

References (28)

1. Cheung AM, Tansey CM, Tomlinson G, et al. Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome. Am J Respir Crit Care Med. 2006;174(5):538-544.
2. Katzenstein AL, Bloor CM, Liebow AA. Diffuse alveolar damage-the role of oxygen, shock, and related factors: a review. Am J Pathol. 1976;85(1):209-228.
3. Idell S, Koenig KB, Fair DS, Martin TR, McLarty J, Maunder RJ. Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. Am J Physiol. 1991;261(4, pt 1):L240-L248.
4. Mandal RV, Mark EJ, Kradin RL. Organizing pneumonia and pulmonary lymphatic architecture in diffuse alveolar damage. Hum Pathol. 2008;39(8): 1234-1238.
5. Churg A, Sin DD, Everett D, Brown K, Cool C. Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol. 2009;33(12): 1765-1770.
6. Silva CI, M? uller NL, Fujimoto K, et al. Acute exacerbation of chronic interstitial pneumonia: high-resolution computed tomography and pathologic findings. J Thorac Imaging. 2007;22(3):221-229.
7. Kradin RL, Digumarthy SR, Baggish AL, Mark EJ. Case records of the Massachusetts General Hospital: case 12-2010-an 89-year-old man with progressive dyspnea. N Engl J Med. 2010;362(16):1522-1531.
8. Churg A, Wright JL, Tazelaar HD. Acute exacerbations of fibrotic interstitial lung disease. Histopathology. 2011;58(4):525-530.
9. Katzenstein AL, Myers JL, Mazur MT. Acute interstitial pneumonia. A clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol. 1986; 10(4):256-267.
10. Vourlekis JS, Brown KK, Schwarz MI. Acute interstitial pneumonitis: current understanding regarding diagnosis, pathogenesis, and natural history. Semin Respir Crit Care Med. 2001;22(4):399-408.
11. Fischer A, Meehan RT, Feghali-Bostwick CA, West SG, Brown KK. Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease. Chest. 2006;130(4):976-981.
12. Zisman DA, Keane MP, Belperio JA, Strieter RM, Lynch JP III. Pulmonary fibrosis. Methods Mol Med. 2005;117:3-44.
13. Churg A, Myers J, Suarez T, et al. Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung disease. Am J Surg Pathol. 2004;28(1):62- 68.
14. Yousem SA. Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia: a proposal. Mod Pathol. 2006;19(1):1474-1479.
15. King TE Jr, Schwarz MI, Brown K, et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med. 2001;164(6):1025-1032.
16. Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998;157(1):199-203.
17. Berbescu EA, Katzenstein AL, Snow JL, Zisman DA. Transbronchial biopsy in usual interstitial pneumonia. Chest. 2006;129(5):1126-1131.
18. Diaz de Leon A, Cronkhite JT, Katzenstein AL, et al. Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS One. 2010;5(5): e10680. doi:10.1371/journal.pone.0010680.
19. Katzenstein AL. Smoking-related interstitial fibrosis (SRIF), pathogenesis and treatment of usual interstitial pneumonia (UIP), and transbronchial biopsy in UIP. Mod Pathol. 2012;25(suppl 1):S68-S78.
20. Katzenstein AL, Zisman DA, Litzky LA, Nguyen BT, Kotloff RM. Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am J Surg Pathol. 2002;26(12):1567-1577.
21. Tafti SF, Mokri B, Mohammadi F, Bakhshayesh-Karam M, Emami H, Masjedi MR. Comparison of clinicoradiologic manifestation of nonspecific interstitial pneumonia and usual interstitial pneumonia/idiopathic pulmonary fibrosis: a report from NRITLD. Ann Thorac Med. 2008;3(4):140-145.
22. Song JW, Do KH, Kim MY, Jang SJ, Colby TV, Kim DS. Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest. 2009;136(1):23-30.
23. Amin RS, Wert SE, Baughman RP, et al. Surfactant protein deficiency in familial interstitial lung disease. J Pediatr. 2001;139(1):85-92.
24. American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 2004; 170(6):691-715.
25. Capron F. New classification of interstitial lung disease [in French]. Rev Pneumol Clin. 2005;61(3):133-140.
26. Mark EJ, Ruangchira-urai R. Bronchiolitis interstitial pneumonitis: a pathologic study of 31 lung biopsies with features intermediate between bronchiolitis obliterans organizing pneumonia and usual interstitial pneumonitis, with clinical correlation. Ann Diagn Pathol. 2008;12(3):171-180.
27. Mathai SK, Nishino M, O'Donnell W, Kradin RL. The presence of intraalveolar fibrin in lung biopsies of organizing pneumonia predicts severity of prognosis. Am J Respir Crit Care Med. 2012;185(1):A1590.
28. Santo Tomas LH. Beryllium hypersensitivity and chronic beryllium lung disease. Curr Opin Pulm Med. 2009;15(2):165-169.